United States News All stories

Software giant Microsoft (NASDAQ:MSFT) and computer hardware manufacturers Dell Technologies (NYSE:DELL) and HP (NYSE:HPE) saw their shares rise in premarket trading on Monday morning following a major market expansion announcement from artificial intelligence chip heavyweight Nvidia (NASDAQ:NVDA).

Yum Brands (NYSE:YUM) is in exclusive negotiations to sell its Pizza Hut chain to private equity firm LongRange Capital, according to sources familiar with the matter.

Greenwich LifeSciences (NASDAQ:GLSI) reported new open-label immune response data from its ongoing Phase III FLAMINGO-01 clinical trial evaluating its lead immunotherapy candidate, GLSI-100, in patients with HER2-positive breast cancer.

Rallybio (NASDAQ:RLYB) and Avenzo Therapeutics announced Monday that they have entered into a definitive agreement to combine through a merger transaction.

Rocky Mountain Chocolate Factory (NASDAQ:RMCF) reported its financial and operating results for the fiscal fourth quarter and full year ended February 28, 2026, revealing a planned contraction in lower-margin sales alongside structural improvements in its underlying expense profile and product profit margins.

SOLAI (NYSE:SLAI) has reached an agreement to acquire a controlling interest in a Singaporean artificial intelligence developer, accelerating its corporate pivot away from cryptocurrency mining operations toward an AI-first infrastructure platform.

ParaZero Technologies (NASDAQ:PRZO) has secured its first commercial order from an unnamed U.S.-based Tier-1 defense corporation for its proprietary DefendAir Net Pods.

Welltower (NYSE:WELL) has announced that it expects to increase its quarterly common dividend by 15% to $0.85 per share, beginning with the second quarter of 2026.

AstraZeneca (NASDAQ:AZN) unveiled positive data from its late-stage EMERALD-3 clinical trial on Monday, demonstrating that adding its dual-immunotherapy regimen to standard localized therapy significantly slows disease progression in patients battling early-stage, unresectable liver cancer.

Kamada (NASDAQ:KMDA) announced Monday that the U.S. Food and Drug Administration has approved its new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) rabies virus neutralization laboratory at its manufacturing plant in Beit Kama, Israel.

Marex Group (NASDAQ:MRX) announced Monday that it has acquired Levmet, a Monaco-based liquidity provider, in a move to strengthen its physical market-making operations and secure a firmer foothold in European power and gas trading.

Jade Biosciences (NASDAQ:JBIO) delivered a significant milestone for its autoimmune pipeline, reporting positive interim results from its Phase 1 clinical trial evaluating JADE101.

Monopar Therapeutics (NASDAQ:MNPR) announced encouraging mid-stage clinical results for its investigational Wilson disease therapy, demonstrating widespread stabilization in liver pathology alongside substantial neurological and quality-of-life improvements.

C1 Fund (NYSE:CFND) released its financial results for the first quarter ended March 31, 2026, revealing a net asset value (NAV) of $48,906,337, or $7.34 per share, against a backdrop of accelerating initial public offering activity within its private digital asset portfolio.

Citius Oncology (NASDAQ:CTOR) showcased positive early-stage clinical trial results, demonstrating the potential of its targeted immune therapy LYMPHIR to enhance the efficacy of checkpoint inhibitors in treating recurrent or refractory gynecologic cancers.

Invivyd (NASDAQ:IVVD) completed enrollment for the pivotal Phase 3 clinical trial of its leading monoclonal antibody candidate, positioning the biotechnology firm to deliver late-stage results later this quarter.

Science Applications International Corp. (NASDAQ:SAIC) raised its full-year profitability and earnings forecasts after a steady opening quarter marked by expanding operating margins and an accumulation of new federal contract awards.

Bristol Myers Squibb (NYSE:BMY) secured a major regulatory milestone on Monday as the European Commission approved its blockbuster immunotherapy Opdivo in combination with chemotherapy for patients fighting advanced blood cancer.

Motorola Solutions (NYSE:MSI) has entered into a definitive agreement to acquire counter-drone technology leader D-Fend Solutions for a total purchase price of $1.5 billion, marking an aggressive move to secure a dominant position in the rapidly expanding airspace security market.

Community Financial System (NYSE:CBU) has finalized its acquisition of ClearPoint Federal Bank & Trust in an all-cash transaction valued at $39 million, absorbing a prominent administrator within the niche death care asset management market.

Parsons (NYSE:PSN) announced Monday that it has been awarded a $99 million single-award task order from the U.S. Air Force Research Laboratory (AFRL) to expand its development of advanced tactical command and control systems alongside space-based intelligence architectures.

FedEx (NYSE:FDX) completed the separation of its less-than-truckload operational unit on Monday, launching FedEx Freight Holding Company (NYSE:FDXF) as an independent, publicly traded entity on the New York Stock Exchange.

Kenon Holdings (NYSE:KEN) delivered a substantial acceleration in top-line growth for the first quarter of 2026, heavily driven by strategic operational scaling and asset consolidation within its primary power generation subsidiary, OPC Energy.

Robo.ai (NASDAQ:AIIO) announced Monday that it has officially finalized the 100% equity acquisition of Neurovia AI.